So Min Lee Selected Research

So Min Lee Research Topics

Disease

8	Inflammation (Inflammations) 08/2020 - 06/2010
7	Insulin Resistance 06/2022 - 11/2014
7	Atherosclerosis 11/2018 - 01/2010
6	Obesity 12/2020 - 01/2017
4	Edema (Dropsy) 02/2015 - 01/2012
3	Ototoxicity 04/2022 - 05/2020
3	Hearing Loss (Hearing Impairment) 04/2022 - 01/2020
3	Nephrosis 02/2015 - 05/2012
3	Diabetic Angiopathies (Diabetic Angiopathy) 11/2014 - 01/2012
2	Deafness (Deaf Mutism) 06/2021 - 11/2020
2	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2021 - 01/2021
2	Alcoholic Fatty Liver 12/2020 - 10/2020
2	Non-alcoholic Fatty Liver Disease 12/2020 - 10/2020
2	Leiomyoma (Uterine Fibroids) 11/2020 - 01/2019
1	Hyperpigmentation 06/2022
1	Headache (Headaches) 02/2022
1	Fatigue 02/2022
1	Sleep Wake Disorders 02/2022
1	Neuroinflammatory Diseases 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020
1	Diabetes Complications 08/2020
1	Rhinitis 11/2019
1	Memory Disorders (Memory Loss) 05/2019
1	Myoma 01/2019
1	Stroke (Strokes) 11/2018
1	Neoplasms (Cancer) 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Nephrocalcinosis 06/2016
1	Heterotopic Ossification (Ectopic Ossification) 01/2016
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2016
1	Uremia 02/2015

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 02/2015
3	CholesterolIBA 10/2020 - 01/2012
3	CytokinesIBA 01/2017 - 01/2010
2	Kanamycin FDA Link 04/2022 - 11/2021
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 06/2021 - 11/2020
2	Insulin (Novolin)FDA Link 12/2020 - 01/2017
2	LipidsIBA 12/2020 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2012
2	Therapeutic UsesIBA 10/2020 - 08/2020
2	AdipokinesIBA 08/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2015
2	oryeongsanIBA 06/2016 - 02/2015
2	Heme Oxygenase-1IBA 01/2014 - 01/2012
2	Aquaporins (Water Channels)IBA 01/2014 - 01/2012
2	Cell Adhesion MoleculesIBA 01/2013 - 06/2010
2	NF-kappa B (NF-kB)IBA 06/2010 - 01/2010
1	Nicotinamide MononucleotideIBA 06/2022
1	Pharmaceutical PreparationsIBA 06/2022
1	AminoglycosidesIBA 04/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2022
1	Pravastatin (Pravachol)FDA LinkGeneric 04/2022
1	Pharmaceutical Sleep AidsIBA 02/2022
1	saponarinIBA 02/2022
1	Telmisartan (Micardis)FDA Link 11/2021
1	Thyroid HormonesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	AldosteroneIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Vasopressins (Vasopressin)IBA 01/2021
1	ResveratrolIBA 12/2020
1	yijin-tangIBA 12/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2020
1	MelatoninIBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Glycerophospholipids (Phosphoglycerides)IBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	SphingolipidsIBA 10/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2020
1	CeramidesIBA 08/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2020
1	Monounsaturated Fatty AcidsIBA 08/2020
1	Triglycerides (Triacylglycerol)IBA 08/2020
1	LeptinIBA 08/2020
1	AdiponectinIBA 08/2020
1	zingeroneIBA 05/2020
1	ursodoxicoltaurineIBA 01/2020
1	Ointments (Pastes)IBA 11/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2019
1	Scopolamine (Hyoscine)FDA Link 05/2019
1	AcetylcholinesteraseIBA 05/2019
1	Caspase 9IBA 01/2019
1	keishibukuryoganIBA 01/2019
1	oxidized low density lipoproteinIBA 11/2018
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2018
1	Shao-Fu-Zhu-YuIBA 01/2017
1	ORALIT (ORS)IBA 06/2016
1	wulingsanIBA 06/2016
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2016
1	Cell Adhesion Molecule-1IBA 02/2015
1	ThymidineIBA 02/2015

Therapy/Procedure

2	Therapeutics 06/2022 - 02/2015